A TCRβ Repertoire Signature Can Predict Experimental Cerebral Malaria

Encarnita Mariotti-Ferrandiz1,2,3,4,5, Hang-Phuong Pham4,5, Sophie Dulauroy1,2,3

  • 1Sorbonne Universités, UPMC Univ Paris 06, URA 1961 CNRS, F-75005, Paris, France.

Plos One
|February 5, 2016
PubMed

Insights

Cerebral malaria (CM) involves T cell alterations. Researchers identified a specific T cell receptor beta (TCRβ) signature in blood and spleen that predicts CM onset in mice, offering potential diagnostic biomarkers.

Area of Science:

  • Immunology
  • Pathology
  • Infectious Diseases

Background:

  • Cerebral malaria (CM) is linked to detrimental T cell responses.
  • Mice with experimental CM (CM+) show altered peripheral blood lymphocyte (PBL) T cell receptor (TCR) repertoires compared to controls.

Purpose of the Study:

  • To investigate the relationship between TCR repertoire alterations and CM development.
  • To perform a kinetic analysis of the T cell receptor beta variable (TRBV) repertoire during Plasmodium berghei ANKA (PbA) infection until CM onset.

Main Methods:

  • Compared TCR repertoires of PBL, splenocytes, and brain lymphocytes in infected and non-infected mice.
  • Utilized high-throughput CDR3 spectratyping for repertoire analysis.
  • Applied multivariate analysis and statistical modeling to identify disease signatures.

Main Results:

  • Observed significant modifications in the overall TCR repertoire in the spleen and blood by days 5 and 6 post-infection, respectively.
  • Found only three TRBV genes were significantly perturbed in the brain.
  • Identified a unique TCRβ signature in blood and spleen that distinguishes CM+ from control mice and predicts CM onset.

Conclusions:

  • TCR diversity undergoes dynamic modification and compartmentalization during PbA infection.
  • The identified TCRβ signature serves as a potential diagnostic and prognostic biomarker for CM.

Related Concept Videos